¼¼°èÀÇ À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå º¸°í¼­(2025³â)
Implantable Heart Pacemaker Global Market Report 2025
»óǰÄÚµå : 1659158
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,339,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,163,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,987,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 5.7%·Î 64¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¸ÂÃãÇü ÀÇ·á ¹× ¸ÂÃãÈ­, ½ÅÈï ½ÃÀå È®´ë, ¿¡³ÊÁö È¿À²ÀûÀÎ ÀåÄ¡¿¡ ´ëÇÑ ÁÖ·Â, ¼ÒÇüÈ­ ¹× ³»±¸¼º¿¡ ´ëÇÑ ÁÖ·Â, Ȩ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ È®´ë, ±ÔÁ¦ÀÇ ÁøÀü°ú Ç¥ÁØÈ­¿¡ ±âÀÎÇÑ´Ù°í ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¹«¼± ¿¬°á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ, MRI Áö¿ø ½É¹ÚÁ¶À²±â, ÀΰøÁö´É(AI) ÅëÇÕ, ½º¸¶Æ®Æù ¿¬°á ¹× ¾Û, ¸®µå ÃßÃâ ±â¼ú, ¿ø°Ý ÀÇ·á ÅëÇÕ, ȯÀÚ Âü¿© µîÀÌ ÀÖ½À´Ï´Ù.

À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀåÀÌ ¿¹»óµÇ´Â ¹è°æÀ¸·Î´Â ½ÉÀå ¹ßÀÛ, ´ç´¢º´, °íÇ÷¾Ð, ½É¹æ ¼¼µ¿°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¸¸¼º ÁúȯÀº º¸Åë 3°³¿ù ÀÌ»ó Áö¼ÓµÇ¸ç ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ¾ÇÈ­µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ½Ä °¡´ÉÇÑ ½É¹Ú Á¶À²±â´Â Á¤±âÀûÀÎ ½ÉÀå ¸®µëÀ» À¯ÁöÇÏ¿© ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¹Úµ¿À» ÇØ°áÇÏ°í ½ÉÀå ¸¶ºñ¿Í °°Àº ½ÉÀå ÁúȯÀ» ¿¹¹æÇÏ°í °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î 2022³â ¹Ì±¹ Áúº´ ¿¹¹æ°ü¸®¼¾ÅÍ Åë°è¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â Àα¸ÀÇ 11.3%¿¡ ÇØ´çÇÏ´Â ¾à 3,730¸¸ ¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖ½À´Ï´Ù. ±¹Á¦ ´ç´¢º´ ¿¬ÇÕÀº Àü ¼¼°èÀûÀ¸·Î ¾à 5¾ï 3,700¸¸ ¸íÀÇ ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, ±× 4ºÐÀÇ 3ÀÌ Àú¼Òµæ ¹× Áß»êÃþ±¹°¡¶ó°í º¸°íÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼º ÁúȯÀÇ ±ÞÁõÀº À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.

º´¿øÀÇ ÀÇ·á ¼­ºñ½º ¼ö¿ä Áõ°¡´Â À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´ÀÎÀ̳ª ºÎ»óÀÚ¿¡°Ô ÀǷḦ Á¦°øÇÏ´Â Àü¹® ½Ã¼³ÀÎ º´¿ø¿¡¼­´Â À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿¸¦ ³Î¸® Ȱ¿ëÇÏ¿© ½ÉÀå Áúȯ °ü¸®, ½ÉÀå ¸®µë Á¶Á¤, ȯÀÚ ¿ø°Ý ¸ð´ÏÅ͸µÀ» ½Ç½ÃÇß½À´Ï´Ù. ½É¹Ú Á¶À²±â´Â ½É¹Ú¼ö¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϰí ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ Å©°Ô ±â¿©ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Interweave Textiles Limited¿¡ µû¸£¸é, 2023³â 8¿ù ÇöÀç ¿µ±¹¿¡´Â 1,148°³ÀÇ º´¿øÀÌ ÀÖÀ¸¸ç, 930°³ÀÇ ±¹¹Î º¸°Ç ¼­ºñ½º º´¿ø°ú 218°³ÀÇ »ç¸³ º´¿øÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ç°­ °ü¸® ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó À̽ÄÇü ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°,±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A pacemaker is a small device implanted in the chest to regulate heartbeat, preventing it from slowing down excessively.

Implantable heart pacemakers come in several types such as single-chamber, dual-chamber, and biventricular. The single-chamber pacemaker employs a single lead connected to either the right atrium or right ventricle of the heart. It finds application in treating conditions like heart block, sick sinus syndrome, diagnosing heart diseases, and is utilized across various settings such as hospitals, clinics, households, and others.

The implantable heart pacemaker market research report is one of a series of new reports from The Business Research Company that provides implantable heart pacemaker market statistics, including implantable heart pacemaker industry global market size, regional shares, competitors with an implantable heart pacemaker market share, detailed implantable heart pacemaker market segments, market trends and opportunities, and any further data you may need to thrive in the implantable heart pacemaker industry. This implantable heart pacemaker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable heart pacemaker market size has grown steadily in recent years. It will grow from $4.97 billion in 2024 to $5.18 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to advancements in cardiac care, aging population demographics, improved diagnosis and screening tools, increased prevalence of heart failures, rise in cardiovascular risk factors, clinical research and development, regulatory support and approvals.

The implantable heart pacemaker market size is expected to see strong growth in the next few years. It will grow to $6.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to personalized medicine and customization, expansion in emerging markets, focus on energy-efficient devices, focus on miniaturization and durability, expansion of home healthcare solutions, regulatory advancements and standards. Major trends in the forecast period include wireless connectivity and remote monitoring, MRI-compatible pacemakers, integration of artificial intelligence (ai), smartphone connectivity and apps, lead extraction techniques, telehealth integration and patient engagement.

The anticipated growth in the implantable heart pacemaker market is attributed to the increasing prevalence of chronic diseases like heart attacks, diabetes, hypertension, and atrial fibrillation. Chronic conditions typically persist for three months or more and may worsen over time. Implantable pacemakers address irregular heartbeats by maintaining a regular cardiac rhythm, aiding in preventing or managing heart diseases like heart attacks. For instance, statistics from the Centers for Disease Control and Prevention in 2022 revealed that around 37.3 million individuals in the United States, equating to 11.3% of the population, suffer from diabetes. Globally, the International Diabetes Federation reported approximately 537 million adults with diabetes, with three-quarters of them in low- and middle-income countries. This surge in chronic conditions is propelling the demand for implantable heart pacemakers.

The increasing demand for healthcare services in hospitals is expected to drive the growth of the implantable heart pacemaker market. Hospitals, specialized facilities providing medical care to the ill or injured, extensively utilize implantable heart pacemakers to manage cardiac conditions, regulate heart rhythm, and monitor patients remotely. They significantly contribute to enhancing patients' overall quality of life by ensuring a consistent and appropriate heart rate. For example, as of August 2023, the UK hosts 1148 hospitals, including 930 National Health Service hospitals and 218 private hospitals, according to Interweave Textiles Limited. This rising demand for healthcare services is fostering the growth of the implantable heart pacemaker market.

Major companies in the implantable heart pacemaker market are prioritizing the development of technologically advanced solutions, including sophisticated cardiac devices, to improve patient outcomes and effectively manage heart conditions. Advanced cardiac devices include a variety of innovative tools, such as leadless pacemakers and cardiac resynchronization therapy devices, designed to optimize heart function. These technologies utilize state-of-the-art materials and software to deliver real-time data and personalized treatment options for patients with heart disease. For example, in November 2023, Abbott Laboratories, a US-based medical device firm, introduced the AVEIR(TM) dual-chamber leadless pacemaker. This device significantly enhances cardiac care by removing complications associated with traditional leads, which are prone to fracturing or infection. Its dual-chamber capability facilitates synchronized pacing of both the atrium and ventricle, thereby improving heart rhythm coordination and patient outcomes.

Major companies in the implantable heart pacemaker market are prioritizing product approvals, such as the dual chamber (DR) leadless pacemaker system, to drive revenue growth. This pioneering technology offers a minimally invasive, leadless solution for patients with slow heart rates. For instance, in July 2023, Abbott Laboratories received FDA approval for the aveir dual chamber (DR) leadless pacemaker system. Utilizing the body's conductive properties, this system delivers low-energy, subthreshold pulses between implanted devices to provide cardiac pacing therapy while sensing intrinsic cardiac signals, marking the first dual-chamber leadless pacemaker.

In November 2022, Johnson & Johnson acquired Abiomed for $16.6 billion, aiming to bolster its position in cardiovascular innovation and improve heart failure care. Abiomed, a company specializing in medical devices that aid heart functions, is now part of Johnson & Johnson MedTech (JJMT), aligning with the healthcare giant's commitment to advancing cardiac care and recovery solutions.

Major companies operating in the implantable heart pacemaker market are Medtronic PLC, BIOTRONIK Inc., Boston Scientific Corporation, Abbott Laboratories, MEDICO SRL, Vitatron, Shree Pacetronix Ltd., Sorin Group, Osypka Medical GmbH, OSCOR Inc., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC., MicroPort Scientific Corporation, Cardioelectronica, Hunan Zhongyi Medical Devices Co. Ltd., Shenzhen MicroCor Medical Technology Co.Ltd., Nanjing Normative Biological Technology Co. Ltd., Beijing Huibo Cardiovascular Devices Co. Ltd., Jiangsu Kanghui Medical Devices Co. Ltd., Zhejiang Lewei Medical Instruments Co. Ltd., Shandong Weigao Medical Devices Co. Ltd., Liaoning Tianma Medical Technology Co. Ltd., Changsha Leadshine Medical Devices Co. Ltd.

North America was the largest region in the implantable heart pacemaker market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable heart pacemaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable heart pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable heart pacemaker market consists of sales of external pacemakers and leadless pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Heart Pacemaker Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable heart pacemaker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for implantable heart pacemaker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable heart pacemaker market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Implantable Heart Pacemaker Market Characteristics

3. Implantable Heart Pacemaker Market Trends And Strategies

4. Implantable Heart Pacemaker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Heart Pacemaker Growth Analysis And Strategic Analysis Framework

6. Implantable Heart Pacemaker Market Segmentation

7. Implantable Heart Pacemaker Market Regional And Country Analysis

8. Asia-Pacific Implantable Heart Pacemaker Market

9. China Implantable Heart Pacemaker Market

10. India Implantable Heart Pacemaker Market

11. Japan Implantable Heart Pacemaker Market

12. Australia Implantable Heart Pacemaker Market

13. Indonesia Implantable Heart Pacemaker Market

14. South Korea Implantable Heart Pacemaker Market

15. Western Europe Implantable Heart Pacemaker Market

16. UK Implantable Heart Pacemaker Market

17. Germany Implantable Heart Pacemaker Market

18. France Implantable Heart Pacemaker Market

19. Italy Implantable Heart Pacemaker Market

20. Spain Implantable Heart Pacemaker Market

21. Eastern Europe Implantable Heart Pacemaker Market

22. Russia Implantable Heart Pacemaker Market

23. North America Implantable Heart Pacemaker Market

24. USA Implantable Heart Pacemaker Market

25. Canada Implantable Heart Pacemaker Market

26. South America Implantable Heart Pacemaker Market

27. Brazil Implantable Heart Pacemaker Market

28. Middle East Implantable Heart Pacemaker Market

29. Africa Implantable Heart Pacemaker Market

30. Implantable Heart Pacemaker Market Competitive Landscape And Company Profiles

31. Implantable Heart Pacemaker Market Other Major And Innovative Companies

32. Global Implantable Heart Pacemaker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Heart Pacemaker Market

34. Recent Developments In The Implantable Heart Pacemaker Market

35. Implantable Heart Pacemaker Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â